<DOC>
	<DOCNO>NCT01452815</DOCNO>
	<brief_summary>The purpose study test safety effectiveness two dosage level ( 10mg 20mg ) TZP-102 compare placebo ( capsule look like study drug contains active drug ) , administer once-daily 12 week , diabetic subject symptom associate gastroparesis .</brief_summary>
	<brief_title>Affects Once-daily Oral Administration TZP-102 Treatment Symptoms Associated With Diabetic Gastroparesis</brief_title>
	<detailed_description>Considered subject screen determine eligibility entry study . The Screening Visit must take place least 14 day , 21 day , plan date study entry ( randomization administration first dose study drug Study Day 1 ) . The baseline evaluation gastric empty must schedule least 7 day ( U.S. ) 10 day ( Europe ) Day 1 Visit . Subjects answer question relate gastroparesis symptom electronic diary ( like palm pilot ) begin first day screen period . Eligible subject randomize receive placebo one two dosage TZP-102 ( 10mg 20mg ) daily 12 week . After randomization administration first dose study drug Study Day 1 ( Study Entry Visit ) , subsequent visit clinic schedule every two week 12-week Treatment period 4-week Follow-Up Period . All visit conduct outpatient basis . Visits give subject throughout study schedule start approximately time , morning . Subjects instructed take daily dose study drug morning ( attend study visit ) , least 30 minute breakfast . Subjects instruct take study drug morning treatment period visit bring study drug supply clinic ; study drug administer clinic schedule assessments/procedures ( pre-dose assessment Day 1 Week 12 Visits ) complete .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>18 80 year age , inclusive Type 1 type 2 diabetes mellitus History symptom gastroparesis least 3 month lead Screening Visit Gastric halfemptying time &gt; 82 minute , demonstrate Gastric Emptying Breath Test perform Screening Visit OR document delay gastric empty within previous 24 month Mild moderate severity gastroparesis symptom screen period Body Mass Index ( BMI ) &lt; 45.0 Screening Visit Glycosylated hemoglobin ( HbA1c ) level &lt; 11.0 % Screening Visit Upper gastrointestinal obstruction rule endoscopy barium scan Concomitant medication must stable least 2 week lead Baseline Visit must maintain study . Females childbearing potential must negative serum pregnancy test use ( agree continue use throughout study ) acceptable form contraception . Persistent daily vomit Gastrectomy , bariatric surgery , fundoplication vagotomy/pyloroplasty Has plan endoscopic pyloric injection botulinum toxin within 6 month prior Screening Visit study . NG , PEG PEJ feed tube within 2 week prior Screening Visit Required inpatient hospitalization treatment gastroparesis within 2 week prior Screening Visit Required parenteral nutrition treatment gastroparesis within 2 month prior Screening Visit Active gastric pacemaker within 3 month prior Screening Visit Participated investigational study within 30 day prior Screening Visit Chronic severe diarrhea Diabetic ketoacidosis require inpatient hospitalization within 30 day prior Screening Visit History eat disorder within 2 year prior Screening Visit Chronic obstructive pulmonary disease ( COPD ) chronic asthma Chronic smoker unable unwilling abstain smoke two visit gastric empty breath test perform History risk factor Torsades de Pointes Corrected QT interval calculate use Fredericia 's formula &gt; = 500 msec , record confirm three ECG assessment perform screening period Bradycardia hypotension assess clinicallysignificant investigator Requires treatment concomitant medication substrate Cytochrome P450 isoenzyme 3A4 know clinically recognize risk Torsades de Pointes History acute myocardial infarction , unstable angina transient ( cerebral ) ischemic attack within 12 month prior Screening Visit History severe depression , psychiatric disorder cognitive impairment History alcohol drug abuse dependency within 2 year prior Screening Visit Taking opiates abdominal pain Known history Hepatitis B C HIV infection Requires dialysis elevate creatinine Screening Visit Abnormal liver function test Screening Visit Uncontrolled hypo hyperthyroidism Adrenal insufficiency Active malignancy basal cell squamous cell carcinoma skin Pregnant breastfeeding Allergies component breath test meal severe lactose intolerance Any medical condition social circumstance , investigator 's opinion , make inappropriate patient participate clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>diabetic gastroparesis</keyword>
	<keyword>delay gastric empty</keyword>
	<keyword>gastroparesis</keyword>
	<keyword>diabetes mellitus , Type 1</keyword>
	<keyword>diabetes mellitus , Type 2</keyword>
</DOC>